Clinical Trial

Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

Name: Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia — clinical trial record (NCT07530666)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

A study to evaluate the safety, tolerability, and preliminary efficacy of DS010 in patients with cancer and cachexia

Trial Details

NCT Number	NCT07530666
Lead Sponsor	Dartsbio Pharmaceuticals Ltd.
Conditions	Cancer, Cachexia
Enrollment	58 participants
Start Date	2026-04-30
Primary Completion	2027-10-30 (estimated)
Study Completion	2028-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-15